SEC Form 4 · accession 0001547522-16-000253
IMMUCELL CORP /DE/ · ICCC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph H Crabb
Officer — Vice President and CSO · Director
Period of report
Jul 1, 2016
Accepted (ET)
Jul 6, 2016 · 9:42 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811641
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.10 per share | Jul 1, 2016 | S | 74 | $7.00 | D | 115,037 | D | |
| Common Stock, par value $0.10 per share | Jul 1, 2016 | S | 1,200 | $6.90 | D | 113,837 | D | |
| Common Stock, par value $0.10 per share | Jul 1, 2016 | S | 200 | $6.95 | D | 113,637 | D | |
| Common Stock, par value $.10 per share | Jul 1, 2016 | S | 200 | $6.90 | D | 113,437 | D | |
| Common Stock, par value $0.10 per share | Jul 1, 2016 | S | 500 | $6.93 | D | 112,937 | D | |
| Common Stock, par value $0.10 per share | Jul 1, 2016 | S | 100 | $6.955 | D | 112,837 | D | |
| Common Stock, par value $0.10 per share | Jul 1, 2016 | S | 100 | $6.735 | D | 112,737 | D | |
| Common Stock, par value $0.10 per share | Jul 1, 2016 | S | 100 | $6.74 | D | 112,637 | D | |
| Common Stock, par value $0.10 per share | Jul 1, 2016 | S | 100 | $6.785 | D | 112,537 | D | |
| Common Stock, par value $0.10 per share | Jul 1, 2016 | S | 200 | $6.70 | D | 112,337 | D | |
| Common Stock, par value $0.10 per share | Jul 5, 2016 | S | 1,100 | $6.60 | D | 111,237 | D | |
| Common Stock, par value $0.10 per share | Jul 5, 2016 | S | 1,300 | $6.56 | D | 109,937 | D | |
| Common Stock, par value $0.10 per share | Jul 5, 2016 | S | 100 | $6.5601 | D | 109,837 | D | |
| Common Stock, par value $0.10 per share | Jul 5, 2016 | S | 100 | $6.62 | D | 109,737 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transactions reported herein have been effectuated pursuant to a plan implemented by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.